NetworkNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) to Present at 17th Annual Congress of International Drug Discovery Science & Technology 2019
INmune Bio (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, this morning announced that its Director of Neuroscience, C.J. Barnum, and Co-Founder and CEO, R.J. Tesi, M.D., will present at the 17th Annual Congress of International Drug Discovery Science & Technology. The event, scheduled to take place in Japan on July 26, 2019, brings together immunotherapy industry leaders and provides a unique opportunity to connect scientists and facilitate the exchange of ideas and developments. According to the update, Dr. Tesi’s talk is titled, “Combination Immunotherapy to Overcome Resistance to…







